SCM
JAZZ icon

Sterling Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sterling Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Sell
14,615
-2,843
-16% -$497K 0.05% 266
2025
Q4 		$2.97M Buy
17,458
+11,121
+175% +$1.7M 0.05% 281
2025
Q3 		$835K Sell
6,337
-404
-6% -$48.5K 0.01% 694
2025
Q2 		$715K Sell
6,741
-6,863
-50% -$746K 0.01% 757
2025
Q1 		$1.69M Sell
13,604
-1,611
-11% -$210K 0.03% 415
2024
Q4 		$1.87M Buy
15,215
+1,260
+9% +$149K 0.03% 435
2024
Q3 		$1.55M Buy
+13,955
New +$1.53M 0.02% 447
2019
Q3 		$2.13M Sell
16,636
-7,417
-31% -$994K 0.02% 402
2019
Q2 		$3.43M Buy
24,053
+18,550
+337% +$2.49M 0.03% 298
2019
Q1 		$787K Sell
5,503
-28,017
-84% -$3.65M 0.01% 669
2018
Q4 		$4.16M Buy
+33,520
New +$4.97M 0.05% 245
2014
Q4 		– Sell
-10,808
Closed -$1.74M – 934
2014
Q3 		$1.74M Buy
10,808
+1,600
+17% +$246K 0.02% 426
2014
Q2 		$1.35M Hold
9,208
– – 0.01% 514
2014
Q1 		$1.28M Sell
9,208
-1,815
-16% -$273K 0.01% 499
2013
Q4 		$1.4M Buy
11,023
+65
+0.6% +$6.73K 0.01% 313
2013
Q3 		$1.01M Buy
+10,958
New +$884K 0.01% 259

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Sterling Capital Management's JAZZ Position: Q1 2026 in Review

Sterling Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q1 2026, selling an estimated $497K and leaving 14,615 shares worth $2.76M. The position accounts for 0.05% of the portfolio, ranked #266.

Sterling Capital Management first reported a position in JAZZ in Q3 2013 and has held it in 16 quarters since. The position peaked at $4.16M in Q4 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Sterling Capital Management held 14,615 shares of Jazz Pharmaceuticals worth $2.76M as of Q1 2026.
  • Sterling Capital Management sold 2,843 Jazz Pharmaceuticals shares in Q1 2026, an estimated $497K.
  • Jazz Pharmaceuticals made up 0.05% of Sterling Capital Management's portfolio in Q1 2026, its #266 holding.
  • Sterling Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 16 quarters since.
  • Sterling Capital Management's Jazz Pharmaceuticals position peaked at $4.16M in Q4 2018.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.